BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31698351)

  • 1. Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy.
    de Muinck Keizer DM; Kerkmeijer LGW; Maspero M; Andreychenko A; van der Voort van Zyp JRN; van den Berg CAT; Raaymakers BW; Lagendijk JJW; de Boer JCJ
    Phys Med Biol; 2019 Dec; 64(23):235008. PubMed ID: 31698351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer.
    de Muinck Keizer DM; Pathmanathan AU; Andreychenko A; Kerkmeijer LGW; van der Voort van Zyp JRN; Tree AC; van den Berg CAT; de Boer JCJ
    Phys Med Biol; 2019 Apr; 64(7):07NT02. PubMed ID: 30794995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
    Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
    Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).
    Nguyen DT; O'Brien R; Kim JH; Huang CY; Wilton L; Greer P; Legge K; Booth JT; Poulsen PR; Martin J; Keall PJ
    Radiother Oncol; 2017 Apr; 123(1):37-42. PubMed ID: 28342648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.
    de Muinck Keizer DM; Kerkmeijer LGW; Willigenburg T; van Lier ALHMW; Hartogh MDD; van der Voort van Zyp JRN; de Groot-van Breugel EN; Raaymakers BW; Lagendijk JJW; de Boer JCJ
    Radiother Oncol; 2020 Oct; 151():88-94. PubMed ID: 32622779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric impact of soft-tissue based intrafraction motion from 3D cine-MR in prostate SBRT.
    de Muinck Keizer DM; Kontaxis C; Kerkmeijer LGW; van der Voort van Zyp JRN; van den Berg CAT; Raaymakers BW; Lagendijk JJW; de Boer JCJ
    Phys Med Biol; 2020 Jan; 65(2):025012. PubMed ID: 31842008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the generalisation of an atlas-based synthetic-CT algorithm to another centre and MR scanner for prostate MR-only radiotherapy.
    Wyatt JJ; Dowling JA; Kelly CG; McKenna J; Johnstone E; Speight R; Henry A; Greer PB; McCallum HM
    Phys Med Biol; 2017 Nov; 62(24):N548-N560. PubMed ID: 29076457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of delivered dose reconstruction for MR-guided SBRT of pancreatic tumors with fast, real-time 3D cine MRI.
    Grimbergen G; Pötgens GG; Eijkelenkamp H; Raaymakers BW; Intven MPW; Meijer GJ
    Radiother Oncol; 2023 May; 182():109506. PubMed ID: 36736589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.
    Keall PJ; Ng JA; Juneja P; O'Brien RT; Huang CY; Colvill E; Caillet V; Simpson E; Poulsen PR; Kneebone A; Eade T; Booth JT
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1015-21. PubMed ID: 27026307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.
    Korpics MC; Rokni M; Degnan M; Aydogan B; Liauw SL; Redler G
    J Appl Clin Med Phys; 2020 Mar; 21(3):184-191. PubMed ID: 31981305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning framework for automatic detection of arbitrarily shaped fiducial markers in intrafraction fluoroscopic images.
    Mylonas A; Keall PJ; Booth JT; Shieh CC; Eade T; Poulsen PR; Nguyen DT
    Med Phys; 2019 May; 46(5):2286-2297. PubMed ID: 30929254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six degrees-of-freedom prostate and lung tumor motion measurements using kilovoltage intrafraction monitoring.
    Huang CY; Tehrani JN; Ng JA; Booth J; Keall P
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):368-75. PubMed ID: 25445555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
    Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR
    Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
    Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
    Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
    Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
    Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
    Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial.
    Neylon J; Ma TM; Savjani R; Low DA; Steinberg ML; Lamb JM; Nickols NG; Kishan AU; Cao M
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1181-1191. PubMed ID: 38160916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
    Shimizu S; Osaka Y; Shinohara N; Sazawa A; Nishioka K; Suzuki R; Onimaru R; Shirato H
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e393-9. PubMed ID: 21658857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial.
    Hewson EA; Nguyen DT; O'Brien R; Kim JH; Montanaro T; Moodie T; Greer PB; Hardcastle N; Eade T; Kneebone A; Hruby G; Hayden AJ; Turner S; Siva S; Tai KH; Hunter P; Sams J; Poulsen PR; Booth JT; Martin J; Keall PJ
    Med Phys; 2019 Nov; 46(11):4725-4737. PubMed ID: 31446633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.